Literature DB >> 28339690

Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations.

Kevin Zhang1, Dina Demner-Fushman2.   

Abstract

OBJECTIVE: To develop automated classification methods for eligibility criteria in ClinicalTrials.gov to facilitate patient-trial matching for specific populations such as persons living with HIV or pregnant women.
MATERIALS AND METHODS: We annotated 891 interventional cancer trials from ClinicalTrials.gov based on their eligibility for human immunodeficiency virus (HIV)-positive patients using their eligibility criteria. These annotations were used to develop classifiers based on regular expressions and machine learning (ML). After evaluating classification of cancer trials for eligibility of HIV-positive patients, we sought to evaluate the generalizability of our approach to more general diseases and conditions. We annotated the eligibility criteria for 1570 of the most recent interventional trials from ClinicalTrials.gov for HIV-positive and pregnancy eligibility, and the classifiers were retrained and reevaluated using these data.
RESULTS: On the cancer-HIV dataset, the baseline regex model, the bag-of-words ML classifier, and the ML classifier with named entity recognition (NER) achieved macro-averaged F2 scores of 0.77, 0.87, and 0.87, respectively; the addition of NER did not result in a significant performance improvement. On the general dataset, ML + NER achieved macro-averaged F2 scores of 0.91 and 0.85 for HIV and pregnancy, respectively. DISCUSSION AND
CONCLUSION: The eligibility status of specific patient populations, such as persons living with HIV and pregnant women, for clinical trials is of interest to both patients and clinicians. We show that it is feasible to develop a high-performing, automated trial classification system for eligibility status that can be integrated into consumer-facing search engines as well as patient-trial matching systems. Published by Oxford University Press on behalf of the American Medical Informatics Association 2017. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  clinical trial screening; eligibility determination; machine learning; natural language processing; patient-trial matching

Mesh:

Year:  2017        PMID: 28339690      PMCID: PMC6080677          DOI: 10.1093/jamia/ocw176

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  16 in total

1.  An overview of MetaMap: historical perspective and recent advances.

Authors:  Alan R Aronson; François-Michel Lang
Journal:  J Am Med Inform Assoc       Date:  2010 May-Jun       Impact factor: 4.497

2.  Agreement, the f-measure, and reliability in information retrieval.

Authors:  George Hripcsak; Adam S Rothschild
Journal:  J Am Med Inform Assoc       Date:  2005-01-31       Impact factor: 4.497

Review 3.  Including persons with HIV infection in cancer clinical trials.

Authors:  Govind C Persad; Richard F Little; Christine Grady
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

4.  Analysis of eligibility criteria representation in industry-standard clinical trial protocols.

Authors:  Sanmitra Bhattacharya; Michael N Cantor
Journal:  J Biomed Inform       Date:  2013-06-12       Impact factor: 6.317

5.  Clinical research enrolling pregnant women: a workshop summary.

Authors:  Mary A Foulkes; Christine Grady; Catherine Y Spong; Angela Bates; Janine A Clayton
Journal:  J Womens Health (Larchmt)       Date:  2011-08-05       Impact factor: 2.681

Review 6.  Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

Authors:  D A Braunholtz; S J Edwards; R J Lilford
Journal:  J Clin Epidemiol       Date:  2001-03       Impact factor: 6.437

7.  Electronic screening improves efficiency in clinical trial recruitment.

Authors:  Samir R Thadani; Chunhua Weng; J Thomas Bigger; John F Ennever; David Wajngurt
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

8.  Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.

Authors:  Yizhao Ni; Jordan Wright; John Perentesis; Todd Lingren; Louise Deleger; Megan Kaiser; Isaac Kohane; Imre Solti
Journal:  BMC Med Inform Decis Mak       Date:  2015-04-14       Impact factor: 2.796

9.  Trial prospector: matching patients with cancer research studies using an automated and scalable approach.

Authors:  Satya S Sahoo; Shiqiang Tao; Andrew Parchman; Zhihui Luo; Licong Cui; Patrick Mergler; Robert Lanese; Jill S Barnholtz-Sloan; Neal J Meropol; Guo-Qiang Zhang
Journal:  Cancer Inform       Date:  2014-12-04

10.  Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department.

Authors:  Yizhao Ni; Stephanie Kennebeck; Judith W Dexheimer; Constance M McAneney; Huaxiu Tang; Todd Lingren; Qi Li; Haijun Zhai; Imre Solti
Journal:  J Am Med Inform Assoc       Date:  2014-07-16       Impact factor: 4.497

View more
  9 in total

Review 1.  Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records.

Authors:  Guergana K Savova; Ioana Danciu; Folami Alamudun; Timothy Miller; Chen Lin; Danielle S Bitterman; Georgia Tourassi; Jeremy L Warner
Journal:  Cancer Res       Date:  2019-08-08       Impact factor: 12.701

2.  Evaluation of patient-level retrieval from electronic health record data for a cohort discovery task.

Authors:  Steven R Chamberlin; Steven D Bedrick; Aaron M Cohen; Yanshan Wang; Andrew Wen; Sijia Liu; Hongfang Liu; William R Hersh
Journal:  JAMIA Open       Date:  2020-07-26

3.  ELaPro, a LOINC-mapped core dataset for top laboratory procedures of eligibility screening for clinical trials.

Authors:  Ahmed Rafee; Sarah Riepenhausen; Philipp Neuhaus; Alexandra Meidt; Martin Dugas; Julian Varghese
Journal:  BMC Med Res Methodol       Date:  2022-05-14       Impact factor: 4.612

Review 4.  How can natural language processing help model informed drug development?: a review.

Authors:  Roopal Bhatnagar; Sakshi Sardar; Maedeh Beheshti; Jagdeep T Podichetty
Journal:  JAMIA Open       Date:  2022-06-11

5.  Automated NLP Extraction of Clinical Rationale for Treatment Discontinuation in Breast Cancer.

Authors:  Matthew S Alkaitis; Monica N Agrawal; Gregory J Riely; Pedram Razavi; David Sontag
Journal:  JCO Clin Cancer Inform       Date:  2021-05

6.  Semantic categorization of Chinese eligibility criteria in clinical trials using machine learning methods.

Authors:  Hui Zong; Jinxuan Yang; Zeyu Zhang; Zuofeng Li; Xiaoyan Zhang
Journal:  BMC Med Inform Decis Mak       Date:  2021-04-15       Impact factor: 2.796

Review 7.  Musculoskeletal care - at the confluence of data science, sensors, engineering, and computation.

Authors:  Suchitra Kataria; Vinod Ravindran
Journal:  BMC Musculoskelet Disord       Date:  2022-02-22       Impact factor: 2.362

8.  A comparative study of pre-trained language models for named entity recognition in clinical trial eligibility criteria from multiple corpora.

Authors:  Jianfu Li; Qiang Wei; Omid Ghiasvand; Miao Chen; Victor Lobanov; Chunhua Weng; Hua Xu
Journal:  BMC Med Inform Decis Mak       Date:  2022-09-06       Impact factor: 3.298

9.  Automated classification of clinical trial eligibility criteria text based on ensemble learning and metric learning.

Authors:  Kun Zeng; Yibin Xu; Ge Lin; Likeng Liang; Tianyong Hao
Journal:  BMC Med Inform Decis Mak       Date:  2021-07-30       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.